Vocabria (Cabotegravir)

cabotegravir 30 mg tablet, 30 · ORAL · PBS code 12939B

STREAMLINED

What it costs

AU$632.27 PBS-determined price per 30 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2022-04-01.
• Repeats: 0.
• PBS program: CA.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

HIV infection

Patient must be virologically suppressed on a stable antiretroviral regimen for at least 6 months; AND

The treatment must be in combination with rilpivirine tablets; AND

Patient must intend to proceed to treatment with intramuscular administration of cabotegravir and rilpivirine.

Sponsor: ViiV Healthcare Pty Ltd ABN 46 138 687 448

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.